{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T12:34:28Z","timestamp":1795264468004,"version":"4.10.3"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Randomized controlled trials (RCTs) enrolling patients at high cardiovascular risk have found that influenza vaccination may reduce the incidence of cardiovascular events. We performed an updated meta-analysis assessing the effect of influenza vaccination on the incidence of cardiovascular events in patients with ischaemic heart disease or heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We searched PubMed, EMBASE and other sources to identify RCTs examining the effect of influenza vaccination on the incidence of cardiovascular events assessed as efficacy outcomes in patients with ischaemic heart disease or heart failure. Eligible studies followed patients for at least one influenza season, defined as a minimum duration of 6\u2009months. The primary endpoint was a composite of cardiovascular death, acute coronary syndrome, stent thrombosis or coronary revascularization, stroke or heart failure hospitalization. The secondary endpoints were cardiovascular death and all-cause death. Two investigators independently identified and extracted data from studies. Results were compared using hazard ratios (HRs) in both random effects and fixed effects models. We included five peer-reviewed and one non peer-reviewed RCTs for a total of 9340 patients. Five trials included patients with ischaemic heart disease (n\u2009=\u20094211) and one trial included patients with heart failure (n\u2009=\u20095129). Influenza vaccination was associated with a reduced incidence of the primary composite endpoint (random effects HR [rHR] 0.74, 95% confidence interval [CI] 0.63\u20130.88, p\u2009&amp;lt;\u20090.001, I2\u2009=\u200952%), cardiovascular death (rHR 0.63, 95% CI 0.42\u20130.95, p\u2009=\u20090.028, I2\u2009=\u200958%) and all-cause death (rHR 0.72, 95% CI 0.54\u20130.95, p\u2009=\u20090.0227, I2\u2009=\u200952%). Results were similar when non peer-reviewed data were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this meta-analysis of available RCTs in patients at high cardiovascular risk, influenza vaccination was associated with a reduced incidence of cardiovascular events, cardiovascular death and all-cause death as compared to placebo or no treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.2945","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T23:38:37Z","timestamp":1687909117000},"page":"1685-1692","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis"],"prefix":"10.1093","volume":"25","author":[{"given":"Daniel","family":"Modin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats Christian H\u00f8jbjerg","family":"Lassen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Dyrby","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Keshtkar-Jahromi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Grundtvig","family":"Skaarup","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Nealon","sequence":"additional","affiliation":[{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Udell","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, Women's College Hospital , Toronto, ONT ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gislason","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]},{"name":"Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte , Copenhagen ,","place":["Denmark"]},{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"2026010913103216500_ejhf2945-bib-0001","volume-title":"Cardiovascular diseases (CVDs)","author":"World Health Organization"},{"key":"2026010913103216500_ejhf2945-bib-0002","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2307\/4580606","article-title":"Excess mortality from causes other than influenza and pneumonia during influenza epidemics","volume":"47","author":"Collins","year":"1932","journal-title":"Public Health Rep"},{"key":"2026010913103216500_ejhf2945-bib-0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2026010913103216500_ejhf2945-bib-0004","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2026010913103216500_ejhf2945-bib-0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2026010913103216500_ejhf2945-bib-0006","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.17.1900199","article-title":"Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016","volume":"25","author":"Ohland","year":"2020","journal-title":"Euro Surveill"},{"key":"2026010913103216500_ejhf2945-bib-0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med"},{"key":"2026010913103216500_ejhf2945-bib-0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13054-014-0469-1","article-title":"Effects of intra-abdominal sepsis on atherosclerosis in mice","volume":"18","author":"Kaynar","year":"2014","journal-title":"Crit Care"},{"key":"2026010913103216500_ejhf2945-bib-0009","first-page":"11","article-title":"Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries","volume":"34","author":"Madjid","year":"2007","journal-title":"Tex Heart Inst J"},{"key":"2026010913103216500_ejhf2945-bib-0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk: A meta-analysis","volume":"5","author":"Behrouzi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026010913103216500_ejhf2945-bib-0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2019.02.009","article-title":"Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design","volume":"212","author":"Loeb","year":"2019","journal-title":"Am Heart J"},{"key":"2026010913103216500_ejhf2945-bib-0012","author":"Influenza Vaccine to Prevent Adverse Vascular Events - IVVE"},{"key":"2026010913103216500_ejhf2945-bib-0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026010913103216500_ejhf2945-bib-0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2026010913103216500_ejhf2945-bib-0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"2026010913103216500_ejhf2945-bib-0016","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"},{"key":"2026010913103216500_ejhf2945-bib-0017","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"2026010913103216500_ejhf2945-bib-0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"2026010913103216500_ejhf2945-bib-0019","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"key":"2026010913103216500_ejhf2945-bib-0020","first-page":"S395","article-title":"The efficacy of influenza vaccination in reducing cardiovascular events in patients with coronary artery diseases: IVCAD study","volume":"15","author":"Keshtkar-Jahromi","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2026010913103216500_ejhf2945-bib-0021","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: A multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026010913103216500_ejhf2945-bib-0022","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11886-022-01748-8","article-title":"Influenza vaccination for cardiovascular prevention: Further Insights from the IAMI trial and an updated meta-analysis","volume":"24","author":"Maniar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2026010913103216500_ejhf2945-bib-0023","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"2026010913103216500_ejhf2945-bib-0024","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/HJH.0b013e3283331169","article-title":"Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study","volume":"28","author":"de Simone","year":"2010","journal-title":"J Hypertens"},{"key":"2026010913103216500_ejhf2945-bib-0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure","volume":"139","author":"Daniel","year":"2019","journal-title":"Circulation"},{"key":"2026010913103216500_ejhf2945-bib-0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2009.09.108","article-title":"Antibody response to influenza immunization in coronary artery disease patients: A controlled trial","volume":"28","author":"Keshtkar-Jahromi","year":"2009","journal-title":"Vaccine"},{"key":"2026010913103216500_ejhf2945-bib-0027","volume-title":"PROSPERO: International Prospective Register of Systematic Reviews","author":"National Institute for Health and Care Research"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/9\/1685\/65559860\/eurjhf_25_9_1685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/9\/1685\/65559860\/eurjhf_25_9_1685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:13:09Z","timestamp":1767982389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/9\/1685\/8341897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,5]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2945","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"2022-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}